INFINITY PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Infinity Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2023 was $84K, a 54.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $84K -$101K -54.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $138K -$68K -33% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $194K +$140K +259% Dec 31, 2022 10-Q 2023-08-10
Q3 2022 $384K +$352K +1100% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $185K +$144K +351% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $206K +$205K +20500% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $54K +$49K +980% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $32K +$23K +256% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $41K +$28K +215% Jun 30, 2021 10-Q 2021-07-27
Q1 2021 $1K -$15K -93.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $5K -$210K -97.7% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $9K -$400K -97.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $13K -$400K -96.9% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $16K -$506K -96.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $215K -$154K -41.7% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $409K -$316K -43.6% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $413K -$312K -43% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $522K -$226K -30.2% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $369K -$379K -50.7% Dec 31, 2018 10-K 2020-03-03
Q3 2018 $725K +$702K +3052% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $725K +$697K +2489% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $748K +$713K +2037% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $748K +$707K +1724% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $23K -$317K -93.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $28K -$359K -92.8% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $35K -$2.32M -98.5% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $41K -$2.34M -98.3% Dec 31, 2016 10-K 2018-03-15
Q3 2016 $340K -$7K -2.02% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $387K +$54K +16.2% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $2.36M +$2M +558% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $2.38M +$1.98M +494% Dec 31, 2015 10-K 2017-03-14
Q3 2015 $347K -$86K -19.9% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $333K -$28K -7.76% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $358K +$270K +307% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $401K +$354K +753% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $433K +$397K +1103% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $361K +$329K +1028% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $88K +$63K +252% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $47K -$40K -46% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $36K -$78K -68.4% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $32K -$24K -42.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $25K -$99K -79.8% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $87K -$56K -39.2% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $114K -$41K -26.5% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $56K -$23.8K -29.8% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $124K Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $143K +$1.15K +0.81% Dec 31, 2011 10-K 2013-03-05
Q3 2011 $155K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $79.8K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $142K Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.